| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 677,964 | 670,460 | 702,667 | 821,944 | | Cost of Revenue | 44,175 | 54,637 | 57,482 | 64,819 | | | Gross Profit | 633,789 | 615,823 | 645,185 | 757,125 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 415,692 | 347,853 | 400,472 | 463,661 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 301,638 | 282,693 | 356,053 | 229,595 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (83,541) | (14,723) | (111,340) | 63,869 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (83,541) | (14,723) | (111,340) | 63,869 | | Interest Expense | 29,331 | 71,969 | 102,614 | 111,771 | | Income Before Tax | (112,872) | (86,692) | (213,954) | (47,902) | | Income Tax Expense | (47,777) | (30,988) | (88,859) | (28,821) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (65,095) | (55,704) | (125,095) | (19,081) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (65,095) | (55,704) | (125,095) | (19,081) | | Preferred Stock And Other Adjustments | (17,706) | (7,413) |
-
|
-
| | | Net Income Applicable To Common Shares | ($82,801) | ($63,117) | ($125,095) | ($19,081) |
|
0.45% Nasdaq 
0.20%
Income Statement
